Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.67 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.49 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorescein SCHEMBL5192892 | 1.00 | FTO (0.67) | FTOMAPTMEN1KMT2ATDP1 | |
| Ammonia Solution, Strong SCHEMBL4630176 | 0.99 | FTO (0.66) | FTOMAPTMEN1KMT2ATDP1 | |
| Ammonia Solution, Strong SCHEMBL4630175 | 0.99 | FTO (0.66) | FTOMAPTMEN1KMT2ATDP1 | |
| Ammonia Solution, Strong SCHEMBL3654611 | 0.99 | FTO (0.66) | FTOMAPTMEN1KMT2ATDP1 | |
| Ammonia Solution, Strong SCHEMBL3654615 | 0.99 | FTO (0.66) | FTOMAPTMEN1KMT2ATDP1 | |
| Naphthalene SCHEMBL7987484 | 0.97 | FTO (0.64) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL32675203 | 0.92 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL991335 | 0.92 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL17688356 | 0.91 | FTO (0.72) | FTOMAPTMEN1KMT2ATDP1 | |
| Ammonia Solution, Strong SCHEMBL29101292 | 0.91 | FTO (0.72) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | claimed |
| US-12422429-B2 | Methods for reducing noise in signal-generating digital assays | ABBOTT JAPAN LLC (JP) | 2025-09-23 | — | — | US | claimed |
| US-12275782-B2 | Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells | MERZ PHARMA GMBH & CO. KGAA (DE) | 2025-04-15 | — | — | US | claimed |
| US-20240270833-A1 | Means and Methods for the Determination of the Biological Activity of Neurotoxin Polypeptides in Cells | MERZ PHARMA GMBH & CO. KGAA (DE) | 2024-08-15 | — | — | US | claimed |
| CN-110520734-B | Method for reducing noise in signal-generating digital assays | 雅培日本有限责任公司 | 2024-07-09 | — | — | CN | claimed |
| US-11976110-B2 | Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells | MERZ PHARMA GMBH & CO. KGAA (DE) | 2024-05-07 | — | — | US | claimed |
| US-20240011108-A1 | MASS SPECTROMETRY-BASED METHODS AND KITS FOR NUCLEIC ACID DETECTION AND DISEASE DIAGNOSTIC | YYZ PHARMATECH INC. (CA) | 2024-01-11 | — | — | US | claimed |
| EP-4232598-A1 | MASS SPECTROMETRY-BASED METHODS AND KITS FOR NUCLEIC ACID DETECTION AND DISEASE DIAGNOSTIC | YYZ Pharmatech Inc. (CA) | 2023-08-30 | — | — | EP | claimed |
| CN-116391047-A | Mass spectrometry-based methods and kits for nucleic acid detection and disease diagnosis | YYZ医药科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| WO-2022087730-A1 | MASS SPECTROMETRY-BASED METHODS AND KITS FOR NUCLEIC ACID DETECTION AND DISEASE DIAGNOSTIC | YYZ PHARMATECH INC. (CA) | 2022-05-05 | — | — | WO | claimed |
| US-20030154501-A1 | Compound screening method | DEVGEN, N.V. (BE) | 2003-08-14 | — | — | US | claimed |
| US-20030124576-A1 | Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-07-03 | — | — | US | claimed |
| US-20030096253-A1 | Single nucleotide amplification and detection by polymerase | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-05-22 | — | — | US | claimed |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-04-24 | — | — | US | claimed |
| WO-2003020984-A2 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES AND METHODS OF USE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| WO-2003020891-A2 | SINGLE NUCLEOTIDE AMPLIFICATION AND DETECTION BY POLYMERASE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| WO-2003020734-A2 | LABELED NUCLEOSIDE POLYPHOSPHATES | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| EP-1175506-A2 | COMPOUND SCREENING METHOD | Devgen NV (BE) | 2002-01-30 | — | — | EP | claimed |
| WO-2000063427-A2 | COMPOUND SCREENING METHOD | DEVGEN NV (BE) | 2000-10-26 | — | — | WO | claimed |
| US-5830666-A | USING A FLUORESCEIN DERIVATIVE PHOSPHATE ESTER | AISIN SEIKI KABUSHIKI KAISHA (JP) | 1998-11-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030124576-A1 | Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases | PNP, RNGTT, MTAP | FTO 584/4885MAPT 4154/4885MEN1 3990/4885 |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | RNGTT, DNTT, PNP | FTO 902/4885MAPT 3256/4885MEN1 4285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.